Latest news
VRDN Stock Records Biggest Single Day Gains In 45 Months – And It’s Not Just Due To A Better-Than-Feared Q1 Loss - StocktwitsStocktwits · Sat, 08 Aug 2026 09:59:11 GMTViridian Therapeutics (VRDN) Stock Rises Despite Deepening Losses And Cash Burn - simplywall.stsimplywall.st · Sat, 08 Aug 2026 06:03:54 GMTVRDN SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocusGuruFocus · Sat, 08 Aug 2026 05:27:18 GMTVRDN Maintained by RBC Capital -- Price Target Raised to $36.00 - GuruFocusGuruFocus · Fri, 07 Aug 2026 22:56:08 GMTViridian Therapeutics to See 'Minimal' Revenue Growth in H2, RBC Capital Markets Says - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 16:05:30 GMTState Street Corporation (NASDAQ: VRDN) discloses 5.5% Viridian Therapeutics ownership - Stock TitanStock Titan · Fri, 07 Aug 2026 15:13:34 GMTRBC Adjusts Viridian Therapeutics PT to $36 From $35, Maintains Outperform Speculative Risk Rating - MoomooMoomoo · Fri, 07 Aug 2026 14:05:17 GMTA Quick Look at Today's Ratings for Viridian Therapeutics(VRDN.US), With a Forecast Between $22 to $41 - MoomooMoomoo · Fri, 07 Aug 2026 13:00:02 GMT